Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,163
Recruiting: 2,261
Ph III recruiting: 270
Growth YoY: +12.5%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 14,251–14,260 of 14,260 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00172640	Genetic Studies in Liver Cancer Patients	unknown	—	40	National Taiwan University HospitalOTHER	1	Sep 15, 2005	clinicaltrials
NCT00155272	Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma	unknown	Phase 1 / Phase 2	19	National Taiwan University HospitalOTHER	1	Sep 12, 2005	clinicaltrials